Healthequity (HQY) Depreciation & Amortization (CF) (2013 - 2026)

Healthequity has reported Depreciation & Amortization (CF) for 14 years, with the latest figure at $38.7 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 1.28% year-over-year to $38.7 million; the trailing twelve-month figure through Jan 2026 stood at $154.7 million (down 4.8% YoY), and the FY2026 full-year result was $154.7 million, down 4.8% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $38.7 million, roughly flat from $38.8 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $43.6 million in Q3 2024, with the low at $37.8 million in Q4 2023.
• Average Depreciation & Amortization (CF) over 5 years is $39.4 million, with a median of $38.9 million recorded in 2024.
• Year-over-year, Depreciation & Amortization (CF) increased 27.63% in 2022 and decreased 11.82% in 2025.
• Tracing HQY's Depreciation & Amortization (CF) over 5 years: stood at $40.5 million in 2022, then retreated by 6.72% to $37.8 million in 2023, then climbed by 7.78% to $40.7 million in 2024, then fell by 4.77% to $38.8 million in 2025, then dropped by 0.25% to $38.7 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $38.7 million (Q1 2026), $38.8 million (Q4 2025), and $38.5 million (Q3 2025), per Business Quant data.

Peer Comparison